比利时克罗恩病患者未满足的健康相关需求:一种混合方法研究
Claudia Schönborn1, Muriel Levy2, Mats De Jaeger2
1Belgian Health Care Knowledge Centre (KCE), Boulevard du Jardin Botanique 55, Brussels, 1000, Belgium. Claudia.schoenborn@kce.fgov.be.
概括
克罗恩病患者面临着重大未满足的需求,包括延迟诊断和负担重重的心理症状,影响生活质量. 改善心理支持和更快的诊断对于更好的患者护理至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 患者报告的结果
- 医疗保健服务研究 医疗服务研究
背景情况:
- 测量与健康相关的未满足需求对于识别创新差距至关重要.
- 克罗恩病的发病率正在上升,在了解病因或治疗方面取得的进展有限.
- 未满足需求评估的标准化方法有助于跨疾病的比较.
研究的目的:
- 测量比利时成年克罗恩病患者与健康相关的未满足需求.
- 确定未满足需求的特定领域,包括健康,医疗保健和社会方面.
- 为改善护理和解决创新差距制定有针对性的战略提供信息.
主要方法:
- 在线调查 (n=150) 和半结构面试 (n=20) 与成年克罗恩病患者.
- 调查数据的描述性统计数据和面试成绩单的专题分析.
- 预先将未满足的需求分为健康,医疗保健和社会领域.
主要成果:
- 五分之一的患者经历了超过一年的诊断延迟.
- 75%的人报告有严重的身体症状 (腹,疲劳,);40%的人经历了严重的心理困扰 (压力,焦虑,抑郁).
- 隐形症状导致了社会退缩,影响了个人生活;心理支持不足,40%的人希望更多地参与治疗.
结论:
- 克罗恩病患者承受着相当大的身体和心理症状负担,严重影响生活质量.
- 虽然专家护理足够,但更快的诊断和增强的心理支持是关键的未满足需求.
- 未来的研究应该解决儿科和青少年克罗恩病患者群体尚未满足的需求.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
329
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Chronic Bowel Disorders: Introduction
420
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
420
Chronic Pancreatitis II: Collaborative Care
78
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
78
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120


